Literature DB >> 6871094

Hyperactivity of fibroblasts cultured from psoriatic skin: I. Faster proliferation and effect of serum withdrawal.

G C Priestley, L W Adams.   

Abstract

Fibroblasts were cultured from the involved and uninvolved forearm skin of patients with severe generalized psoriasis and compared with those from the forearms of normal controls of similar ages. Thirteen strains were obtained from involved skin (PSA strains) and sixteen strains from uninvolved skin (PSB), with thirteen control strains (NSF). Outgrowth of fibroblasts from the psoriatic skin explants was slightly quicker than from control skin and the average proliferation rates of passaged strains were PSA 144, PSB 134 and NSF 94 (P less than 0.05). Psoriatic fibroblasts were abnormally dependent on serum for anchorage. In serum-free medium many cells rounded up and were only loosely attached to the substratum. This effect was rapid, reversible and not corrected by adding fibronectin. Cell attachment assays showed only small differences between the psoriatic and normal fibroblasts and the main effect of serum withdrawal appeared to be on spreading rather than attachment. These data suggest that the dermis of both involved and uninvolved psoriatic skin is abnormal and that the hyperactivity persists in vitro. Our findings seem most compatible with a hyperproliferative reaction of both epidermis and dermis to an extracutaneous, perhaps vascular, stimulus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871094     DOI: 10.1111/j.1365-2133.1983.tb07075.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Contraction of collagen lattices by skin fibroblasts: drug-induced changes.

Authors:  L W Adams; G C Priestley
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

2.  PUVA treatment of human cultured fibroblasts from psoriatic skin enhances the binding of antibodies to SSA(Ro).

Authors:  U Wollina; H Beensen; L Kittler; H Schaarschmidt; B Knopf
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis.

Authors:  Li-Hao Huang; Bernd H Zinselmeyer; Chih-Hao Chang; Brian T Saunders; Andrew Elvington; Osamu Baba; Thomas J Broekelmann; Lina Qi; Joseph S Rueve; Melody A Swartz; Brian S Kim; Robert P Mecham; Helge Wiig; Michael J Thomas; Mary G Sorci-Thomas; Gwendalyn J Randolph
Journal:  Cell Metab       Date:  2018-11-08       Impact factor: 27.287

Review 4.  Psoriatic science.

Authors:  C M Rowland Payne
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-07

5.  Inhibition of psoriatic cell proliferation in in vitro skin models by amiprilose hydrochloride.

Authors:  M L Chapman; S D Dimitrijevich; J C Hevelone; D Goetz; J Cohen; G E Wise; R W Gracy
Journal:  In Vitro Cell Dev Biol       Date:  1990-10

6.  Increased phosphorylation of two 48 kDa nuclear proteins in fibroblasts derived from psoriatic patients.

Authors:  M Späder; G Unteregger
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Mitogenic effects of sera from normal and psoriatic subjects on human skin fibroblasts.

Authors:  G C Priestley; L W Adams
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

8.  Vitamin D3 inhibits proliferation and increases c-myc expression in fibroblasts from psoriatic patients.

Authors:  M Casado; M Martin; A Muñoz; J Bernal
Journal:  J Endocrinol Invest       Date:  1998-09       Impact factor: 4.256

Review 9.  Importance of lymphocyte-stromal cell interactions in autoimmune and inflammatory rheumatic diseases.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2021-08-03       Impact factor: 20.543

10.  Increased collagen synthesis in psoriasis in vivo.

Authors:  V Koivukangas; M Kallionen; J Karvonen; H Autio-Harmainen; J Risteli; L Risteli; A Oikarinen
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.